Noah Levy Biography and Net Worth

Noah G. Levy has served as a member of our board of directors since September 2019. Mr. Levy has been a managing member and portfolio manager at Newtyn Management, LLC, an investment firm, since June 2011. Prior to that, Mr. Levy served as a senior member at Tyndall Management, an investment firm, from 2002 to 2011, and as an analyst at Goldman Sachs, an investment bank and financial services company, from 2000 to 2002. Mr. Levy holds a B.A. from Dartmouth College. We believe Mr. Levy is qualified to serve on our board of directors due to his investment management experience and strong financial and business acumen.

What is Noah G. Levy's net worth?: The estimated net worth of Noah G. Levy is at least $16.94 million as of January 12th, 2023. Mr. Levy owns 1,119,586 shares of Merrimack Pharmaceuticals stock worth more than $16,939,336 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Levy may own. Learn More about Noah G. Levy's net worth.
How do I contact Noah G. Levy?: The corporate mailing address for Mr. Levy and other Merrimack Pharmaceuticals executives is ONE BROADWAY 14TH FLOOR, CAMBRIDGE MA, 02142. Merrimack Pharmaceuticals can also be reached via phone at 617-720-8606 and via email at [email protected]. Learn More on Noah G. Levy's contact information.
Has Noah G. Levy been buying or selling shares of Merrimack Pharmaceuticals?: Noah G. Levy has not been actively trading shares of Merrimack Pharmaceuticals during the last ninety days. Most recently, on Thursday, January 12th, Noah G. Levy bought 100,000 shares of Merrimack Pharmaceuticals stock. The stock was acquired at an average cost of $11.90 per share, with a total value of $1,190,000.00. Following the completion of the transaction, the director now directly owns 1,119,586 shares of the company's stock, valued at $13,323,073.40. Learn More on Noah G. Levy's trading history.
Who are Merrimack Pharmaceuticals' active insiders?: Merrimack Pharmaceuticals' insider roster includes Eric Andersen (Director), Gary Crocker (Insider), Noah Levy (Director), and Ulrik Nielsen (Director). Learn More on Merrimack Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Merrimack Pharmaceuticals?: In the last twelve months, Merrimack Pharmaceuticals insiders bought shares 3 times. They purchased a total of 150,600 shares worth more than $1,950,246.40. The most recent insider tranaction occured on December, 28th when Director Eric Andersen bought 857 shares worth more than $11,440.95. Insiders at Merrimack Pharmaceuticals own 30.6% of the company. Learn More about insider trades at Merrimack Pharmaceuticals.
Information on this page was last updated on 12/28/2023.

Noah G. Levy Insider Trading History at Merrimack Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/12/2023	Buy	100,000	$11.90	$1,190,000.00	1,119,586
7/13/2022	Buy	3,095	$5.89	$18,229.55	754,108
7/11/2022	Buy	700	$5.97	$4,179.00	748,197
7/7/2022	Buy	1,100	$5.99	$6,589.00	746,119
6/30/2022	Buy	1,550	$5.76	$8,928.00	745,019
6/23/2022	Buy	500	$6.00	$3,000.00	742,469
6/16/2022	Buy	520	$5.45	$2,834.00	1,012,471
6/14/2022	Buy	20,938	$5.17	$108,249.46	1,010,515
1/31/2022	Buy	1,237	$5.05	$6,246.85
1/28/2022	Buy	12,963	$4.48	$58,074.24
1/26/2022	Buy	19,528	$5.01	$97,835.28
1/10/2022	Buy	14,679	$3.83	$56,220.57
11/24/2020	Buy	69,087	$3.65	$252,167.55
8/13/2020	Buy	608	$3.50	$2,128.00
4/20/2020	Buy	2,325	$3.25	$7,556.25
4/6/2020	Buy	6,042	$3.00	$18,126.00
4/3/2020	Buy	10,750	$2.59	$27,842.50

Noah G. Levy Buying and Selling Activity at Merrimack Pharmaceuticals

Merrimack Pharmaceuticals Company Overview

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $15.13

$15.13

50 Day Range

MA: $14.82

$14.65

$15.13

2 Week Range

Now: $15.13

$11.53

$15.89

Volume

N/A

Average Volume

396,929 shs

Market Capitalization

$223.77 million

P/E Ratio

1.09

Dividend Yield

N/A

Beta

1.45

📉 Warning: Market Crash Predicted - Secure Your Savings

From Behind the Markets | Ad

The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.

Take these 4 steps to protect your retirement here >>>